Electroconvulsive Therapy, Brain-Derived Neurotrophic Factor, and Possible Neurorestorative Benefit of the Clinical Application of Electroconvulsive Therapy
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Treatment-resistant depression (TRD) is a growing problem in psychiatry. A recent meta-analysis has estimated TRD to be as high as 40%. Just over a decade ago, TRD was estimated to be as low as 10% to 15%. The causes of TRD are not fully understood. Finding ways to bring patients to remission faster may be part of the solution, but increasing our understanding of how depression works and how the brain responds to treatment may shed some light on this growing problem. Patients with TRD have been shown to have decreased volumes in gray matter structures, particularly in the hippocampus. Hippocampal volumes are correlated with decreased expression of neurotrophic factors (most notably, brain-derived neurotrophic factor [BDNF]), and decreased expression of BDNF correlates with the presence of depression. Increased expression of BDNF has a strong association with increased volumes in the hippocampus. Electroconvulsive therapy (ECT), a safe and effective treatment of severe depression, has been shown to be effective in TRD. Patients who undergo ECT have also had measurable increases in BDNF, indicating that ECT may be modulating intracellular processes in the patients with depression. Taken together, ECT may have a positive effect on restoring gray matter volume in patients with depression and especially TRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“Furthermore, this study showed that ECS or antidepressant treatment blocked the down-regulation of BDNF mRNA in response to stress.(63)”
BackgroundDiagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 2×
“This same study suggests that treatment resistance can be as high as 60%.(3) Although the causes of TRD are not fully understood, it is clear that its occurrence is on the rise.”
BackgroundMalberg, J. E., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300234 · Cited by 815 · cited 2×
“When fluoxetine was administered between 2 and 8 days after exposure to inescapable shock, no volume reduction in the hippocampus was noted.(50) Depletion of BDNF in animal models has been shown to cause depression.”
BackgroundKellner, C. H., Knapp, R. G., Petrides, G., Rummans, T. A., Husain, M. M., Rasmussen, K., Mueller, M., Bernstein, H. J., O’Connor, K., Smith, G., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1337 · Cited by 471
Frodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.410 · Cited by 394 · cited 1×
“The results of this study suggest that MetBDNF allele carriers might be at greater risk of depression than Val-BDNF allele carriers.(56) Interestingly, BDNF may increase 5HT expression.”
ResultEffect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0578-6 · Cited by 375 · cited 1×
“Measurement of plasma concentrations of BDNF demonstrates lower levels in patients with depression as compared with controls.(53) A postmortem examination of the hippocampus of patients who were taking antidepressants at the time of death compared with patients who were not on antidepressants showed that there was an…”
ResultTardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 1×
“Regulated by cyclic adenosine monophosphate (cAMP) response elementYbinding protein, a protein that is responsible for regulating expression of hormones, transmitters, inflammatory cytokines, and growth factors, BDNF has a role in promoting cell growth and survival, and neuroplasticity in the brain.(58) Brain-derived…”
BackgroundMineralocorticoid Receptor Function in Major Depression
Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.24 · Cited by 204 · cited 2×
“In addition to the influence of secondmessenger systems, BDNF expression seems to be downregulated by increased cortisol levels in the brain and the activation of the hypothalamic-pituitary-adrenal axis.(62) Taylor J ECT & Volume 24, Number 2, June 2008”
BackgroundTaylor, S. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318038fce0 · Cited by 73
Self-citationRegulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells
Chen, B., Wang, J.-F., Sun, X., & Young, L. T. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01551-2 · Cited by 50
Cited by
Peterchev, A. V., Wagner, T. A., Miranda, P. C., Nitsche, M. A., Paulus, W., Lisanby, S. H., Pascual-Leone, A., & Bikson, M. (2012) · Brain Stimulation · doi:10.1016/j.brs.2011.10.001 · Cited by 429
Allen, A. P., Naughton, M., Dowling, J., Walsh, A., Ismail, F., Shorten, G., Scott, L., McLoughlin, D. M., Cryan, J. F., Dinan, T. G., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.033 · Cited by 138
Piccinni, A., Del Debbio, A., Medda, P., Bianchi, C., Roncaglia, I., Veltri, A., Zanello, S., Massimetti, E., Origlia, N., & Domenici, L. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.002 · Cited by 120
Li, Z., Zhang, Y., Wang, Z., Chen, J., Fan, J., Guan, Y., Zhang, C., Yuan, C., Hong, W., Wang, Y., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.003 · Cited by 63
Li, J., Ye, F., Xiao, W., Tang, X., Sha, W., Zhang, X., & Wang, J. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.03.005 · Cited by 53
Metadata
- Authors
- Taylor, S. M.
- Venue
- The Journal of ECT
- Published
- 2008-06
- Volume
- 24
- Issue
- 2
- Pages
- 160-165
- ISSN
- 1095-0680 (ISSN-L)
- OpenAlex
- W2051160885
- Cited by
- 54
- References
- 10
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electroconvulsive Therapy, Brain-Derived Neurotrophic Factor, and Possible Neurorestorative Benefit of the Clinical Application of Electroconvulsive Therapy. https://app.cochat.ai/papers/10.1097/yct.0b013e3181571ad0
- The paper
- Taylor, S. M. (2008). Electroconvulsive Therapy, Brain-Derived Neurotrophic Factor, and Possible Neurorestorative Benefit of the Clinical Application of Electroconvulsive Therapy. The Journal of ECT. https://doi.org/10.1097/yct.0b013e3181571ad0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.